Role of macrophages in complications of type 2 diabetes.
about
Role of T cells in type 2 diabetic nephropathyDiscovery of genes related to diabetic nephropathy in various animal models by current techniques.Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injuryDiabetic neuropathy: mechanisms to managementTLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy.Serum IL-17, IL-23, and TGF-β levels in type 1 and type 2 diabetic patients and age-matched healthy controlsMouse models of diabetic nephropathy.Diabetic neuropathy: clinical manifestations and current treatments.Macrophage stimulating agent soluble yeast β-1,3/1,6-glucan as a topical treatment of diabetic foot and leg ulcers: A randomized, double blind, placebo-controlled phase II studyIdentified single-nucleotide polymorphisms and haplotypes at 16q22.1 increase diabetic nephropathy risk in Han Chinese populationMechanisms of disease: the oxidative stress theory of diabetic neuropathyMacrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases.Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis.Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal InjuryCCL18 synergises with high concentrations of glucose in stimulating fibronectin production in human renal tubuloepithelial cells.Altered polarization, morphology, and impaired innate immunity germane to resident peritoneal macrophages in mice with long-term type 2 diabetes.Alterations in monocyte CD16 in association with diabetes complications.Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury.Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases.New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy.Macrophages directly mediate diabetic renal injury.Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses.Abnormalities in signaling pathways in diabetic nephropathy.Soluble mediators of diabetic macular edema: the diagnostic role of aqueous VEGF and cytokine levels in diabetic macular edema.Role of the potassium channel KCa3.1 in diabetic nephropathy.Nanomedicines for dysfunctional macrophage-associated diseases.Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice.1,5-Anhydroglucitol attenuates cytokine release and protects mice with type 2 diabetes from inflammatory reactions.Cell therapy for diabetic neuropathy using adult stem or progenitor cells.Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.Xanthine Oxidase Activity in Type 2 Diabetes Mellitus Patients with and without Diabetic Peripheral Neuropathy.Folate receptor expression on murine and human adipose tissue macrophages.FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy.Macrophages in diabetic nephropathy in patients with type 2 diabetes.The phenotype and functional alterations of macrophages in mice with hyperglycemia for long term.
P2860
Q26849691-02D49241-F63A-4226-9927-B4814D9DCA0EQ30398783-7CF64ED9-085F-422F-A85E-89DF170C4C8BQ30423561-54B8D24F-ECA6-4716-9317-520BFCDC8C97Q33554384-407C71E9-F408-4E54-8993-0A26E233263CQ33633050-7449693B-B0B9-4F02-954B-54DCC145F9C5Q33786938-F302EC93-F45E-40FB-AC0F-21DAE7DC9AB7Q33821186-E9D44499-87E6-4ED7-8EC8-B626BF63A79EQ34275990-D156A6AA-9B42-45D1-BCB1-99F70F063DBFQ34407913-CE0BC933-D9B7-454A-B83F-AED59F770FB1Q34463264-3B11C178-979C-4D10-9FEE-FD35C75A3387Q34553052-9FBEAB0C-8071-4416-9C66-52A80B333183Q34785236-D3BA28A3-8C4A-4880-A575-94E08DB59B90Q35421401-CD9B2C23-898C-4F41-97F7-1A0674FEC8BAQ35710293-9BB1BD70-A457-4E6F-9660-D39BC722AF25Q36149014-3C0910C3-4A10-482A-9690-D40C7E1DFF1CQ36311773-13E0C3CE-13A1-4E9B-9B73-5E8FB124A89DQ36506979-56B64944-0E8C-4B2D-9DEA-D58408280551Q37142636-1D0E1645-7F46-4258-BD70-F1A6498E5FB8Q37165144-2117EA59-9531-4161-B0EA-AFA78F75DD66Q37180781-0DB754B6-72DD-4BCE-9661-797C04D96D8BQ37440181-7AE793F0-7C16-4D25-B6A3-6401F564B9D0Q37688086-16561DFB-B60F-483A-AC5C-A51DCAC1E9C6Q37708046-E9447E3F-CE56-434C-A3EC-623A06CA4665Q38104680-67791EB9-934E-4D6F-ADCE-15F8A6D9B745Q38223110-C4AEE9C5-BA67-4345-91F0-2A77BD9073AAQ39069052-16A9FE5C-251D-4296-AF93-46A4971B1DCCQ39496640-F4F9E6B5-746C-4A4B-B398-3D54095D19A4Q39717154-12CBEAAC-7B70-4767-8233-9B777B9658EBQ40178258-71DB76C8-E3B8-4B33-A63C-22B5FAC9D888Q41559116-57BD818A-8370-451C-884C-AD7B382C4B50Q42363114-13BF3F08-0689-4A6C-9565-EB78351758BBQ50261811-34A52BBF-C420-4C9B-A112-9B5BD0D05EBDQ50510640-A7DC3A39-CFB9-44CD-B422-A4E6AC4CA69BQ53066280-0AE7CEC6-A249-4FF1-854D-E826B9B2ECA5Q54581112-F37B41AD-4AEF-447D-B6FB-1CE3B3DBA984
P2860
Role of macrophages in complications of type 2 diabetes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Role of macrophages in complications of type 2 diabetes.
@en
type
label
Role of macrophages in complications of type 2 diabetes.
@en
prefLabel
Role of macrophages in complications of type 2 diabetes.
@en
P2860
P1476
Role of macrophages in complications of type 2 diabetes.
@en
P2093
P2860
P304
P356
10.1111/J.1440-1681.2007.04729.X
P577
2007-10-01T00:00:00Z